Senior Epidemiologist; University Research Lecturer
Iona Millwood completed an undergraduate degree in Natural Sciences at the University of Cambridge and a DPhil in Molecular Genetics at the University of Oxford. She worked as a postdoctoral research associate at Imperial College London, on large-scale genetic epidemiological projects including the Northern Finland Birth Cohorts, and also spent several years as a Lecturer at the University of New South Wales, Australia, developing and conducting clinical trials for biomedical methods of HIV prevention in Australia and South-East Asia.
Iona joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 2009, to work on the China Kadoorie Biobank (CKB), including designing and conducting genomic and multi-omic assays to enhance and develop the CKB resources. Current research interests focus on using genetic and molecular epidemiology to understand the aetiology of cardio-metabolic and other chronic diseases, using genetic approaches to identify and evaluate potential drug targets, and investigating the role of infection in cancer risk, and the health effects of alcohol consumption. Iona co-leads a Genetic Epidemiology module for the MSc in Global Health Science and Epidemiology.
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
Mazidi M. et al, (2023), Journal of the American College of Cardiology, 82, 1906 - 1920
Chronic Hepatitis B Virus Infection and Risk of Stroke Types: A Prospective Cohort Study of 500 000 Chinese Adults.
Hamilton EM. et al, (2023), Stroke
MTHFR and risk of stroke and heart disease in a low-folate population: a prospective study of 156 000 Chinese adults.
Bennett DA. et al, (2023), Int J Epidemiol
Genetic influences on alcohol flushing in East Asian populations.
Cho Y. et al, (2023), BMC Genomics, 24
Life-course adiposity and severe liver disease: a Mendelian randomization analysis.
Wang X. et al, (2023), Obesity (Silver Spring)